Clinical Trial

Dominantly Inherited Alzheimer Network (DIAN)

Study acronym: DIAN
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Protocol Amendment History 4 changes
notable Primary completion moved earlier: 2027-07 -> 2026-09 2026-07-21
minor Completion moved earlier: 2027-07 -> 2026-09 2026-07-21
notable Primary completion pushed: 2026-07 -> 2027-07 2026-07-14
minor Completion pushed: 2026-07 -> 2027-07 2026-07-14
Trial Details
NCT Number NCT00869817
Lead Sponsor Washington University School of Medicine
Collaborators: National Institute on Aging (NIA)
Conditions Alzheimer's Disease
Enrollment 700 participants
Start Date 2009-01
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-20